Global Cerebrospinal Fluid (CSF) Management Market: Snapshot
When there is an imbalance between the production and absorption of cerebrospinal fluid (CSF), is known as hydrocephalus. Surplus production of CSF, obstruction of circulation, faulty absorption, or brain atrophy are the key reasons that lead to an increase in CSF. The surplus CSF is saved in subarachnoid spaces of the brain or within the ventricles, and is also known as hydrodynamic CSF disorder. The prevalence of hydrocephalus is mostly seen among the babies at the time of birth but can also be seen in elderly people. If it occurs to a neonatal, it can physically deform the child because CSF continues to build up that leads to expansion of child’s head to accommodate excessive CSF. As compared to the older child or an elderly, the infant head can expand, as their fontanels are not yet closed. Thus, in case if hydrocephalus is left without treating it can be a cause of mental retardation because of the high pressure being applied on nearby tissues causing the brain to atrophy. In addition, increasing cases of neonatal infections and neural tube defects in emerging economies are related to advanced rates of hydrocephalus.
As per TMR, the global cerebrospinal fluid management market is prophesied to rise at 5.5% CAGR during the forecast tenure from 2015 to 2023. The valuation for the market is expected to touch US$ 1.84 bn by the end of 2023 progressing from US$1.13 as estimated in 2014.
Rising Neurological Diseases to Fuel Market Growth
The global cerebrospinal fluid management market is classified on the basis of type of product that is further segmented into CSF drainage system and CSF shunts. CSF drainage system has been further bifurcated into the lumbar drainage system and ventricular drainage system. The CSF shunts segment held major share in the market in 2014. Nevertheless, the CSF drainage systems segment is expected to rise at high CAGR over the forecast period. This growth is attributed to the growing prevalence of neurological diseases among the general population. In addition to that, rising geriatric population diagnosed with neurological diseases such as Parkinson’s and Alzheimer’s disease, growing demand for minimally invasive surgeries, and high funding by private organizations and government are likely to drive the CSF market in the coming years.
Rapid Technological Innovation to boost demand for Cerebrospinal Fluid Management in Developed Economies
On the regional front, the global cerebrospinal fluid management market includes North America, Asia Pacific, Europe, Latin America, and the Rest of the World. Among these regions, North America held the largest share in the market in 2014. During the forecast period, the region is expected to continue its dominance due to rapid technological innovations and increasing geriatric population. On the other hand, Asia Pacific projected to witness high growth over the forecast period between 2015 and 2023. This is mainly because of rising geriatric population, growing demand for minimally invasive surgeries, and increasing medical tourism in emerging economies. However, the high cost of surgical procedures and lack of availability of shunts in developing countries may obstruct the growth of the market in these countries.
But these restraining factors are projected to be reduced with improving healthcare infrastructure and economic development in emerging nations. Rising disposable income that will increase the purchasing power of the people in countries like India, China, and Brazil will also benefit the market growth. Moreover, increasing medical expenditure by governments has also created huge opportunities for the CSF market to grow the emerging economies.
The report has also analyzed some of the major player contributing to the cerebrospinal fluid management market. Medtronic plc, B. Braun Melsungen AG, DePuy Synthes (a J & J Company), Spiegelberg GmbH & Co. KG, Sophysa S.A., and Integra LifeSciences Holding Corporation are some of the leading players in the market.
Techniques in Cerebrospinal Fluid (CSF) Management Market to Gain Clinical Acceptance for Managing Chronic Conditions
The clinical analysis of cerebrospinal fluid (CSF) has become crucial in assessing various neurological diseases. CSF is a clear fluid that moves around and within the organs of central nervous system notably in intracranial and spinal compartments. At any given point in time, 125 mL to 150 mL of CSF is present in the human body, and it goes frequent generation and reabsorption. Choroid plexus produces the major source while the ependymal cells produces the minority one. The composition and quantity of CSF is thus a vital indicator of diagnosis and severity of various neurological conditions, which is a key factor propelling investments in cerebrospinal fluid (CSF) management market. Growing relevance of initiating therapeutic measures based on CSF management has only expanded the horizon for companies in the market. Various techniques to time the lumbar puncture (LP), and advances made in microbiological evaluation have resulted in generating strides in the CSF management. Some of the acute brain conditions where CSF analysis is useful are subarachnoid hemorrhage (SAH) and meningitis or meningoencephalitis. Over the years, CSF analysis has become a useful diagnostic, therapeutic, and prognostic tool in managing demyelinating diseases, particularly helping in understanding of progress of the autoimmune diseases.
The COVID-19 pandemic arising out of the infectious virus has inflicted high mortality and morbidity in affected patient population over the past few months worldwide. The peaks and outbreaks have concerned industries, epidemiologists, policy makers, and the general population at unpredended scale. Though the vaccination programs have started in some countries and picked up pace in others in recent months, the health and economic uncertainties are still persistent. People with cardiovascular disease (CVD), chronic respiratory disease, cancer, and diabetes have been high-risk populations, with young and adult patient populations at the forefront of the vaccination programs. People with neurological diseases are expected to undergo various CSF techniques in coming years. The trend can be ascribed to the rise in elderly population suffering with chronic neurological conditions and the growing adoption of patient engagement models by healthcare providers.
Table of Content
Chapter 1 Preface
1.1 Report Description
1.2 Market Segmentation
1.3 Research Methodology
Chapter 2 Executive Summary
2.1 CSF Management : Market Snapshot
2.2 Global CSF Management Market Share, by Geography, 2014 & 2023 (Value %)
2.3 Global CSF Management Market, by Product Type, 2014 (US$ Mn)
Chapter 3 Global CSF Management Market–Industry Analysis
3.1 Introduction
3.2 Market Dynamics
3.2.1 Market Drivers
3.2.1.1 Increase in the Global Geriatric Population
3.2.1.2 Rise in acceptance of minimally invasive procedures
3.2.1.3
3.2.2 Market Restraints
3.2.2.1 High cost of surgery
3.2.3 Market Opportunities
3.2.3.1 Increasing Awareness and Improving Health Care Infrastructure in Emerging Economies Such as China, India, Brazil, and Russia
3.3 Porter’s Five Force Analysis of the Global CSF Management Market
3.4 Market Attractiveness Analysis – CSF Management Market, by Geography, 2014
3.5 Competitive Landscape - Global CSF Management Market Share, by Key Players, 2014 (%)
Chapter 4 Global CSF Management Market, by Products
4.1 Global Cerebrospinal Fluid (CSF) Management Market Revenue, by Product, 2013–2023, (US$ Mn) and Analysis
4.2 Global CSF Shunts Market Revenue, 2013–2023, (US$ Mn) and Analysis
4.3 Global CSF Drainage Systems Market Revenue, by Product, 2013–2023, (US$ Mn) and Analysis
4.3.1 Ventricular Drainage System and Analysis
4.3.2. Lumbar Drainage System and Analysis
Chapter 5 Global CSF Management Market, by Geography
5.1 North America CSF Management Market Revenue, by Products, 2013–2023 (US$ Mn) and Analysis
5.1.1 U.S. CSF Management Market Revenue, by Products, 2013–2023 (US$ Mn) and Analysis
5.1.2 Canada CSF Management Market Revenue, by Products, 2013–2023 (US$ Mn) and Analysis
5.2 Europe CSF Management Market Revenue, by Products, 2013–2023 (US$ Mn) and Analysis
5.2.1 U.K CSF Management Market Revenue, by Products, 2013–2023 (US$ Mn) and Analysis
5.2.2 Germany CSF Management Market Revenue, by Products, 2013–2023 (US$ Mn) and Analysis
5.2.3 France CSF Management Market Revenue, by Products, 2013–2023 (US$ Mn) and Analysis
5.2.4 Rest of Europe CSF Management Market Revenue, by Products, 2013–2023 (US$ Mn) and Analysis
5.3 Asia Pacific CSF Management Market Revenue, by Products, 2013–2023 (US$ Mn) and Analysis
5.3.1 China CSF Management Market Revenue, by Products, 2013–2023 (US$ Mn) and Analysis
5.3.2 Japan CSF Management Market Revenue, by Products, 2013–2023 (US$ Mn) and Analysis
5.3.3 Rest of Asia Pacific CSF Management Market Revenue, by Products, 2013–2023 (US$ Mn) and Analysis
5.4 Latin America CSF Management Market Revenue, by Products, 2013–2023 (US$ Mn) and Analysis
5.4.1 Brazil CSF Management Market Revenue, by Products, 2013–2023 (US$ Mn) and Analysis
5.4.2 Rest of Latin America CSF Management Market Revenue, by Products, 2013–2023 (US$ Mn) and Analysis
5.5 Rest of World CSF Management Market Revenue, by Products, 2013–2023 (US$ Mn) and Analysis
5.5.1 South Africa CSF Management Market Revenue, by Products, 2013–2023 (US$ Mn) and Analysis
Chapter 6 Recommendations
6.1 Future Trends: Invest in emerging markets such as China, Brazil, and India, among other
6.2 Barriers to Success
Chapter 7 Company Profiles
7.1 DePuy Synthes (a J & J Company)
7.1.1 Company Overview
7.1.2 Product Portfolio
7.1.3 Financial Overview
7.1.4 Recent Developments
7.2 Medtronic plc.
7.2.1 Company Overview
7.2.2 Product Portfolio
7.2.3 Financial Overview
7.2.4 Recent Developments
7.3 B.Braun Melsungen AG
7.3.1 Company Profile
7.3.2 Product Portfolio
7.3.3 Financial Overview
7.3.4 Recent Developments
7.4 Sophysa S.A.
7.4.1 Company Overview
7.4.2 Product Portfolio
7.4.3 Recent Developments
7.5 Spiegelberg GmbH & Co. KG
7.5.1 Company Overview
7.5.2 Product Portfolio
7.5.3 Recent Developments
7.6 Integra LifeSciences Holding Corporation
7.6.1 Company Overview
7.6.2 Product Portfolio
7.6.3 Financial Overview
7.6.4 Recent Developments
7.7 BeckerSmith Medical, Inc.
7.7.1 Company Overview
7.7.2 Product Portfolio
7.7.3 Recent Developments
7.8 Moller Medical GmbH
7.8.1 Company Overview
7.8.2 Product Portfolio
7.8.3 Recent Developments
List of Tables
Table 1: Global Cerebrospinal Fluid Management Market Snapshot
Table 2: Global Cerebrospinal Fluid (CSF) Management Market Revenue, by Product, 2013–2023, (US$ Mn)
Table 3: Global CSF Drainage Systems Market Revenue, by Product, 2013–2023, (US$ Mn)
List of Figures
FIG 1 Market Segmentation: Global CSF Management Market
FIG 2 Global CSF Management Market Share, by Geography, 2014 (%)
FIG 3 Global CSF Management Market Share, by Geography, 2023 (%)
FIG 4 Porter’s Five Forces Analysis
FIG 5 Market Attractiveness: Global CSF Management Market, by Geography, 2014 (Value %)
FIG 6 Competitive Landscape: Global CSF Management Market, by Key Players, 2014 (Value %)
FIG 7 Global CSF Shunts Market Revenue, 2013–2023, (US$ Mn)
FIG 8 Global Ventricular Drainage System Market Revenue, 2013–2023, (US$ Mn)
FIG 9 Global Lumbar Drainage System Market Revenue, 2013–2023, (US$ Mn)
FIG 10 North America CSF Management Market Revenue, by Products, 2013–2023 (US$ Mn)
FIG 11 U.S CSF Management Market Revenue, by Products, 2013–2023 (US$ Mn)
FIG 12 Canada CSF Management Market Revenue, by Products, 2013–2023 (US$ Mn)
FIG 13 Europe CSF Management Market Revenue, by Products, 2013–2023 (US$ Mn)
FIG 14 U.K. CSF Management Market Revenue, by Products, 2013–2023 (US$ Mn)
FIG 15 Germany CSF Management Market Revenue, by Products, 2013–2023 (US$ Mn)
FIG 16 France CSF Management Market Revenue, by Products, 2013–2023 (US$ Mn)
FIG 17 Rest of Europe CSF Management Market Revenue, by Products, 2013–2023 (US$ Mn)
FIG 18 Asia Pacific CSF Management Market Revenue, by Products, 2013–2023 (US$ Mn)
FIG 19 China CSF Management Market Revenue, by Products, 2013–2023 (US$ Mn)
FIG 20 Japan CSF Management Market Revenue, by Products, 2013–2023 (US$ Mn)
FIG 21 Rest of Asia Pacific CSF Management Market Revenue, by Products, 2013–2023 (US$ Mn)
FIG 22 Latin America CSF Management Market Revenue, by Products, 2013–2023 (US$ Mn)
FIG 23 Brazil CSF Management Market Revenue, by Products, 2013–2023 (US$ Mn)
FIG 24 Rest of Latin America CSF Management Market Revenue, by Products, 2013–2023 (US$ Mn)
FIG 25 Rest of World CSF Management Market Revenue, by Products, 2013–2023 (US$ Mn)
FIG 26 South Africa CSF Management Market Revenue, by Products, 2013–2023 (US$ Mn)
FIG 27 Financial Overview: DePuy Synthes, 2012-2014 (US$ Mn)
FIG 28 Financial Overview: Medtronic plc. 2012-2014 (US$ Mn)
FIG 29 Financial Overview: B. Braun Melsungen AG, 2012-2014 (US$ Mn)
FIG 30 Financial Overview: Integra LifeSciences Holding Corporation, 2012-2014 (US$ Mn)
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Cerebrospinal Fluid (CSF) Management Market
